Skip to search formSkip to main contentSkip to account menu

SB 269,652

Known as: SB-269,652, SB269,652 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation
Highly Cited
2010
Highly Cited
2010
The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands… 
2010
2010
The Tetrahydroisoquinoline Derivative SB 269 , 652 Is an Allosteric Antagonist at Dopamine D 3 and D 2 Receptors
In view of the therapeutic importance of dopamine D3 and D2 receptors, there remains considerable interest in novel ligands… 
Highly Cited
2004
Highly Cited
2004
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats
BackgroundThe role of dopamine D3/D2 receptors in the control of locomotion is poorly understood.ObjectivesTo examine the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)